Oncology Venture advancing in all priority programs

Treatment outcomes in cancer care could be significantly improved if there was a way to identify whether or not each individual patient was likely to respond to a specific treatment. Danish biotech Oncology Venture has developed a platform technology to enable such predictions through drug-specific companion diagnostics. BioStock has delved into the major events for […].